Treatment of sleep dysfunction and psychiatric disorders

Current Treatment Options in Neurology

Volumn 8, Issue 5, 2006, Pages 367-375

  Becker, Philip M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CHLORDIAZEPOXIDE; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; DOXEPIN; ESZOPICLONE; HYPERICUM PERFORATUM EXTRACT; HYPNOTIC SEDATIVE AGENT; IMIPRAMINE; INDIPLON; LORAZEPAM; MELATONIN; MIRTAZAPINE; NEFAZODONE; OLANZAPINE; QUETIAPINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALERIAN; ZALEPLON; ZOLPIDEM;

AGITATION; ALTERNATIVE MEDICINE; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONVULSION; COORDINATION DISORDER; DISEASE SEVERITY; DROWSINESS; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SELECTIVITY; FALLING; FATIGUE; HUMAN; HYPERSOMNIA; INSOMNIA; LEARNING THEORY; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL DISEASE; META ANALYSIS; MOOD DISORDER; MYALGIA; NEURALGIA; PSYCHOMOTOR DISORDER; RELAXATION TRAINING; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SLEEP DISORDER; SLEEP THERAPY; SLEEP WALKING; SOMNOLENCE; SYSTEMATIC REVIEW; TRAFFIC ACCIDENT; WANDERING BEHAVIOR; XEROSTOMIA;

EID: 33748472082     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0026-6     Document Type: Review

References (39)

1. Bassetti CL: Sleep and stroke. Semin Neurol 2005, 25:19-32.
2. Spalletta G, Ripa A, Caltagirone C: Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients. Am J Geriatr Psychiatry 2005, 13:108-115.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4, text revision. Washington, DC: American Psychiatric Association; 2000.
4. Ohayon MM, Roth T: Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003, 37:9-15.
5. Perlis ML, Smith LJ, Lyness JM, et al.: Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006, 4:104-113.
6. Breslau N, Roth T, Rosenthal L, Andreski P: Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry 1996, 39:411-418.
7. Ford DE, Kamerow DB: Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989, 262:1479-1484.
8. Chang PP, Ford DE, Mead LA, et al.: Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997, 146:105-114.
9. Bernert RA, Joiner TE Jr, Cukrowicz KC, et al.: Suicidality and sleep disturbances. Sleep 2005, 28:1135-1141.
10. National Institutes of Health: National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005, 28:1049-1057.
11. Benca RM: Mood disorders. In Principles and Practices of Sleep Medicine, edn 4. Edited by Kryger M, Roth T, Demerit W. Philadelphia: Elsevier; 2005:1311-1326.
12. Lawrence RW: Effect of mirtazapine versus fluoxetine on "sleep quality" J Clin Psychiatry 2004, 65:1149-1150.
13. Nierenberg AA, Keefe BR, Leslie VC, et al.: Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999, 60:221-225.
14. Nowell PD, Buysse DJ: Treatment of insomnia in patients with mood disorders. Depress Anxiety 2001, 14:7-18.
15. Jindal RD, Thase ME: Treatment of insomnia associated with clinical depression. Sleep Med Rev 2004, 8:19-30.
16. Smith MT, Perlis ML: Who is a candidate for cognitive-behavioral therapy for insomnia? Health Psychol 2006, 25:15-19.
17. Becker PM: Pharmacologic and nonpharmacologic treatments of insomnia. Neurol Clin 2005,23:1149-1163.
18. Rush AJ, Trivedi MH, Wisniewski SR, et al.: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006, 354:1231-1242.
19. Bootzin R. Stimulus control treatment for insomnia. In Proceedings of the 80th Annual Convention of the American Psychological Association. Washington, DC: American Psychological Association; 1972:395-396.
20. Spielman AJ, Saskin P, Thorpy MJ: Treatment of chronic insomnia by restriction of time in bed. Sleep 1987, 10:45-56.
21. Hauri PJ: Sleep hygiene, relaxation therapy, and cognitive interventions. In Case Studies in Insomnia. Edited by Hauri PJ. New York: Plenum Publishing; 1991:65-84.
22. Espie CA: Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu Rev Psychol 2002, 53:215-243.
23. Lichstein KL, Morin CM: Reatment of Late-Life Insomnia. Thousand Oaks, CA: Sage Publications; 2000.
24. Morin CM, Hauri PJ, Espie CA, et al.: Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999, 22:1134-1156.
25. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med 2004, 164:1888-1896.
26. Rybarczyk B, Stepanski E, Fogg L, et al.: A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psychol 2005, 73:1164-1174.
27. Vallieres A, Morin CM, Guay B: Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. Behav Res Ther 2005, 43:1611-1630.
28. Silber MH: Clinical practice. Chronic insomnia. N Engl J Med 2005, 353:803-810.
29. Borbely AA, Youmbi-Balderer G: Effect of diphenhydramine on subjective sleep parameters and on motor activity during bedtime. Int J Clin Pharmacol Ther Toxicol 1988, 26:392-396.
30. Mendelson WB: A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry 2005, 66:469-476.
31. Becker PM: Trazodone as a hypnotic in major depression. Sleep Med 2004, 5:7-8.
32. Ringdahl EN, Pereira SL, Delzell JE Jr: Treatment of primary insomnia. J Am Board Fam Pract 2004,17:212-219.
33. Mendelson WB, Roth T, Cassella J, et al.: The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev 2004, 8:7-17.
34. Sateia MJ, Nowell PD: Insomnia. Lancet 2004, 364:1959-1973.
35. Krystal AD, Walsh JK, Laska E, et al.: Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003, 26:793-799.
36. Barbera J, Shaprio C: Benefit-risk assessment of zaleplon in the treatment of insomnia. Drug Saf 2005, 28:301-318.
37. Perlis ML, McCall WV, Krystal AD, Walsh JK Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004, 65:1128-1137.
38. Smith MT, Perlis ML, Park A, et al.: Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002, 159:5-11.
39. Morin CM, Belanger L, Bastien C, Vallieres A: Long-term outcome after discontinuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther 2005, 43:1-14.